Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Completed

A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis

NCT03384745

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Investigative Site Birmingham, Alabama, United States
  • Investigative Site San Diego, California, United States
  • Investigative Site DeLand, Florida, United States
  • Investigative Site Sandy Springs, Georgia, United States
View all 60 locations
View Trial Details
Completed

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

NCT02207244

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Birmingham, Alabama, United States
  • Bakersfield, California, United States
  • Los Angeles, California, United States
  • San Diego, California, United States
View all 93 locations
View Trial Details
Completed

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

NCT01988506

Conditions
Ankylosing Spondylitis, Ankylosis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, +90 more
Locations
  • Henri Mondor - Médecine Interne Créteil, France
  • Médecine interne - Hôpital Saint-Antoine Paris, France
  • Service de médecine vasculaire - HEGP Paris, France
  • Service d' Hépato Gastro Entérologie - Hôpital SAINT-ANTOINE Paris, Île-de-France Region, France
View Trial Details
Completed

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

NCT02346240

Conditions
Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Ps0003 317 Mobile, Alabama, United States
  • Ps0003 306 Little Rock, Arkansas, United States
  • Ps0003 301 Beverly Hills, California, United States
  • Ps0003 307 Los Angeles, California, United States
View all 70 locations
View Trial Details
Completed

The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis

NCT03210259

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Total Skin and Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • Dermatology Research Associates Los Angeles, California, United States
View all 49 locations
View Trial Details

Related conditions